Page Tools:

Dx/Rx: Lung Cancer, Second Edition

Author(s): Christopher G. Azzoli, MD, Memorial Sloan-Kettering Cancer Center
Details:
  • ISBN-13: 9781449600396
  • Paperback    162 pages      © 2013
Price: $74.95 US List
Add to Cart

Thoroughly updated and tightly organized into a highly-condensed outline bulleted format, this handy, pocket-sized manual details precise, up-to-date information for diagnosis and treatment of lung cancer. Throughout Dx/Rx: Lung Cancer, Second Edition, tables and figures summarize important clinical data and current professional society recommendations, while salient references direct readers to additional information.

Presented in an easy-to-read format, Dx/Rx: Lung Cancer, Second Edition is a must-have resource for oncologists, internists, primary care physicians, and other health care professionals on the ward or in the clinic.

Epidemiology
Histopathology of Lung Cancer
Molecular Biology of Lung Cancer
Diagnosis and Staging of Lung Cancer
Treatment of Stage IV NSCLC
Treatment of Unresectable Stage III NSCLC
Treatment of Resectable NSCLC (Stages I–IIIA)
Treatment of Small Cell Lung Cancer (SCLC)
Treatment of Common Complications of Lung Cancer
Malignant Pleural Mesothelioma (MPM)
Malignant Thymoma
What the Future Holds

Christopher G. Azzoli, MD-Memorial Sloan-Kettering Cancer Center

Christopher G. Azzoli, MD, graduated from Johns Hopkins University School of Medicine in 1996. He completed his residency training in Internal Medicine at Johns Hopkins Hospital in Baltimore, Maryland, followed by a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center in New York. He was appointed to faculty at Memorial Sloan-Kettering Cancer Center in 2002, and currently serves as an Assistant Member of the institution in the Department of Medicine, Thoracic Oncology Service. His research interests include the development of new chemotherapy drugs for the treatment of advanced non-small cell lung cancer, as well as developing better treatment strategies for patients with early-stage non-small cell lung cancer, which may be treated with surgery. Dr. Azzoli's laboratory research interests include investigation of blood biomarkers to detect the presence of lung cancer in the body in order to measure the success of therapy, or detect early recurrence.